Dr. Mehmet Oz, talk show host and Vice-Chair and Professor of Surgery at Columbia University is perhaps one of the most well-known doctors in the U.S.
During a recent episode on his talk show, a Walgreens pharmacist gave Dr. Oz a flu shot -- which was also given to everyone in his studio audience. (Unfortunately, we cannot post that clip, but you can view that segment here.)
He states that he's been getting the seasonal flu vaccine every year for about ten years.
But what you didn't see in that clip was Dr. Oz stating that when it comes to the swine flu shot, neither his wife nor his four children will get the vaccine (although he will get that one too). This comes up during interviews on both Fox News and CNN, shown in the two videos above.
It's amazing how many doctors have been hoodwinked into believing that the flu shot is a necessity.
Fortunately, he acquiesces to a far healthier approach as it pertains to the rest of his family, and his wife and children will be spared the toxic burden and other potential health hazards inherent with the swine flu vaccine.
It's far less surprising how many corporations are happy to promote the belief that you need a flu shot every year, given how much money they're making off of useless flu vaccines.
Study after study keeps coming to the same conclusion: Flu vaccines DO NOT WORK, and in many cases do more harm than good.
In fact, before the CDC advocated vaccinating children under the age of five, the number of children dying from the flu was very low, and on the decline. Then, in 2003, just after children aged five and under started getting vaccinated, the number of flu deaths skyrocketed.
For this year's flu season, five biopharmaceutical companies have been awarded massive contracts by the U.S. Department of Health and Human Services (HHS) for development and production of more than 195 million doses of swine flu vaccine, in addition to the seasonal flu vaccine.
The companies -- Novartis, GlaxoSmithKline, MedImmune, Australian drug maker CSL, and Sanofi-Pasteur -- will likely make a great deal of money.
CSL has contracts to supply $180 million worth of bulk antigen to the U.S. MedImmune will supply 40 million doses of its live attenuated nasal spray swine flu vaccine for more than $450 million. And Sanofi-Pasteur is providing more than 100 million doses of monovalent swine flu vaccine, a $690 million order.